Loading
Latest filing published 14 Aug 2026 for Revive Therapeutics Ltd.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Michael Frank in Revive Therapeutics Ltd. Between 5 August 2025 and 13 August 2026, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 14 August 2026: an option exercise, in Revive Therapeutics Ltd. Between a trade and the moment it shows up on SEDI, the median delay is 54 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations